NIH-funded research NIH-funded research

Personalized closed-loop treatment for freezing of gait in Parkinson’s disease

Official title: Personalized closed loop treatment of freezing of gait in Parkinson’s disease

Funded at University of California, San Francisco · NIH-11424676 · Data updated 2026-11-12

A new implantable brain device trial aims to reduce freezing of gait in people with Parkinson’s by using on-device brain signals to guide stimulation in real time.

More s Disease research and trials

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionUniversity of California, San Francisco
NIH-funded
Lab location1 site (San Francisco, United States)
Project startSeptember 5, 2026
Project endAugust 31, 2027
Funding year2026
Award (this year)$678,390
NIH project number1UG3NS150165-01
Project IDNIH-11424676 on NIH RePORTER

Who could benefit from this research

Could help

Adults with Parkinson’s disease who experience medication-refractory freezing of gait and are eligible for deep brain stimulation.

Less likely to help

Patients without Parkinson’s disease or without medication-refractory freezing of gait may not benefit from this specific intervention.

What this research studies

This project tests a next-generation deep brain stimulation system that can sense brain activity and adjust stimulation automatically to target freezing episodes in daily life. It will start with validating the device and regulatory steps, then move to enrolling about ten people with medication-refractory freezing of gait who will receive bilateral brain leads and cortical sensors connected to the system. Researchers will collect brain data in clinic and at home to identify neural patterns linked to FoG and to refine personalized stimulation strategies. The work emphasizes safety, regulatory readiness, and patient experience as the device learns when and how to intervene for better mobility.

Why it matters

Potential benefit: If successful, the approach could provide durable, personalized relief from freezing of gait and reduce fall risk for people with Parkinson’s.

How similar studies have gone: Previous DBS approaches helped some patients, but a biomarker-guided, closed-loop system is a newer strategy with potential for greater consistency.

Where this research is happening

  • University of California, San Francisco
    San Francisco, United States
    Active

Researchers

  • Principal investigator: Wang, Doris Du — University of California, San Francisco
  • Study coordinator: Wang, Doris Du

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.